BELLONE, Federica
 Distribuzione geografica
Continente #
EU - Europa 5.786
NA - Nord America 4.342
AS - Asia 3.026
SA - Sud America 927
AF - Africa 97
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.183
Nazione #
US - Stati Uniti d'America 4.241
RU - Federazione Russa 3.189
SG - Singapore 1.338
CN - Cina 797
BR - Brasile 770
IE - Irlanda 625
SE - Svezia 540
IT - Italia 531
HK - Hong Kong 350
DE - Germania 242
FR - Francia 200
VN - Vietnam 167
PL - Polonia 101
FI - Finlandia 96
IN - India 94
GB - Regno Unito 86
CA - Canada 44
AR - Argentina 41
EC - Ecuador 38
NL - Olanda 35
TR - Turchia 35
MX - Messico 34
AT - Austria 33
IQ - Iraq 31
BD - Bangladesh 30
BE - Belgio 27
ZA - Sudafrica 27
CO - Colombia 23
ES - Italia 23
ID - Indonesia 20
JP - Giappone 20
UZ - Uzbekistan 20
PK - Pakistan 19
CL - Cile 15
CI - Costa d'Avorio 14
MA - Marocco 14
VE - Venezuela 13
EG - Egitto 12
KR - Corea 11
PY - Paraguay 11
SA - Arabia Saudita 11
UA - Ucraina 11
LT - Lituania 10
JO - Giordania 9
IL - Israele 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
AZ - Azerbaigian 6
HN - Honduras 6
NG - Nigeria 6
NO - Norvegia 6
BH - Bahrain 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
MY - Malesia 5
PE - Perù 5
TN - Tunisia 5
UY - Uruguay 5
BO - Bolivia 4
DZ - Algeria 4
EE - Estonia 4
GE - Georgia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
OM - Oman 4
TH - Thailandia 4
AL - Albania 3
AU - Australia 3
GT - Guatemala 3
KE - Kenya 3
LK - Sri Lanka 3
NP - Nepal 3
BG - Bulgaria 2
BY - Bielorussia 2
CM - Camerun 2
ET - Etiopia 2
GY - Guiana 2
LB - Libano 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
PA - Panama 1
PT - Portogallo 1
Totale 14.177
Città #
Moscow 875
Ashburn 831
Singapore 703
Dublin 622
Chandler 498
Dallas 498
Hong Kong 309
Nyköping 308
San Jose 244
Beijing 233
Messina 185
The Dalles 141
Munich 124
New York 108
Princeton 104
Los Angeles 95
Warsaw 95
Dearborn 93
Lauterbourg 91
Medford 77
Ann Arbor 70
São Paulo 70
Jacksonville 62
Ho Chi Minh City 58
Catania 55
Des Moines 55
Boardman 52
Buffalo 48
Bremen 45
Guangzhou 41
Turku 39
Shenyang 38
Cambridge 35
Redondo Beach 34
Helsinki 33
Orem 30
Jinan 29
Wilmington 28
Brussels 27
Seattle 27
Tianjin 26
Santa Clara 25
Council Bluffs 24
Curitiba 24
Frankfurt am Main 23
Hanoi 22
Nanjing 22
Belo Horizonte 21
Houston 21
Nuremberg 21
Pune 21
Rio de Janeiro 20
Chennai 19
Chicago 19
Düsseldorf 19
Strasbourg 19
Rome 18
Montreal 17
San Mateo 17
Tashkent 17
Amsterdam 16
Boston 16
Brooklyn 15
Milan 15
Nanchang 15
Abidjan 14
Hebei 14
Johannesburg 14
Mexico City 14
Porto Alegre 14
Quito 14
Tokyo 14
Vienna 14
Brasília 13
Guayaquil 13
Mumbai 13
Palermo 13
Poplar 13
Shanghai 13
Zhengzhou 13
Atlanta 12
Goiânia 12
San Francisco 12
Baghdad 11
Central 11
Denver 11
Falls Church 11
Fremont 11
Manchester 11
Ningbo 11
Stockholm 11
Woodbridge 11
Hangzhou 10
Jakarta 10
Sheung Shui 10
Taizhou 10
Toronto 10
Cairo 9
Campinas 9
Haikou 9
Totale 8.017
Nome #
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 235
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 223
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 220
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 216
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 214
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 212
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 209
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 206
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 205
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 204
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 197
Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review 192
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 191
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 187
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 187
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 186
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 186
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 185
Hyponatremia as a leading sign of hypopituitarism 184
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 179
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 178
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 176
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 173
Alexithymia and inflammatory bowel disease: A systematic review 173
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 170
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 170
Association between anxiety levels and osteoporosis in postmenopausal women. 169
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 164
Anxiety levels as risk factor for osteoporosis in postmenopausal women 163
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 163
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 161
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 159
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 158
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 157
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 156
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 153
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 153
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 152
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 151
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 145
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 145
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 145
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 144
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 144
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 143
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 143
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 139
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 137
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 137
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 136
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 136
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 135
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 134
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 132
Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life 132
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 131
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 130
Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis 129
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 128
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 128
EFFETTO CODA DI ALENDRONATO SULLA DENSITÀ MINERALE OSSEA IN DONNE CON OSTEOPOROSI POSTMENOPAUSALE: POSSIBILE RUOLO DELLA VITAMINA D 124
Health related quality of life and anxiety in patients with Type 2 Diabetes Mellitus 123
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 122
PULSED ELECTROMAGNETIC FIELDS MODULATE SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 121
Pain and Frailty in Hospitalized Older Adults 121
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 120
Quality of life in postmenopausal women: Which role for vitamin D? 119
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs? 118
Bone quality is associated with body composition measurements in patients with type 2 diabetes. 112
An unusual bilateral groin pain after COVID-19 infection in an 82-year-old man 111
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 111
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 111
Changes in Cognitive and Functional Status and in Quality of Life of Older Outpatients during the COVID-19 Pandemic 110
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 109
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 106
The association between hypoparathyroidism and cognitive impairment: a systematic review 106
Vitamin d boosts alendronate tail effect on bone mineral density in postmenopausal women with osteoporosis 101
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 98
IMPATTO DEI LIVELLI DI ANSIA SULLA DENSITÀ MINERALE OSSEA IN DONNE IN POSTMENOPAUSA IN TRATTAMENTO CON BIFOSFONATI ORALI: RISULTATI DI UNO STUDIO DI COORTE LONGITUDINALE 98
Multiple osteoporotic fractures complicating Wolfram syndrome 93
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 92
Fatigue, sarcopenia, and frailty in older adults with inflammatory bowel disease 92
IL PAZIENTE ANZIANO CON MALATTIA INFIAMMATORIA CRONICA INTESTINALE: OSSERVAZIONI IN UN GRUPPO DI PAZIENTI AMBULATORIALI 91
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease 88
Unlocking the Predictive Power of Nutritional Scores in Septic Patients 87
Effects of denosumab on insulin resistance in postmenopausal women with osteoporosis 86
Psychological factors may impact on postmenpausal women fracture risk 86
Vitamin D, bone metabolism, and fracture risk in polycystic ovary syndrome 85
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now 83
Vitamin D as predictor of anxiety levels in postmenopausal women. 81
Magnesium disorders: Myth or facts? 81
Is the Pentagon-Copying Task More than a Cognitive Feature? Associations with Handgrip Strength, Gait Speed, and Frailty in Older Adults 80
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 79
Rates of hypomagnesemia and hypermagnesemia in medical settings 77
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 74
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 73
Sclerostin and vascular pathophysiology 72
SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings 70
What changed in the Italian internal medicine and geriatric wards during the lockdown 69
Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review 68
Totale 13.838
Categoria #
all - tutte 45.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 64 11 29
2021/2022766 6 42 21 27 17 13 106 38 76 127 53 240
2022/20231.822 138 197 92 143 135 156 21 93 743 20 61 23
2023/2024658 33 82 33 71 45 140 33 88 3 13 22 95
2024/20252.637 66 51 44 177 146 92 88 452 597 233 230 461
2025/20267.515 433 544 522 482 680 1.556 994 1.022 971 311 0 0
Totale 14.529